Symbols / SNY Stock $42.96 -1.63% Sanofi

Healthcare • Drug Manufacturers - General • France • NMS
SNY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - General
CEO Ms. Belen Garijo Lopez M.D.
Exch · Country NMS · France
Market Cap 102.84B
Enterprise Value 66.54B
Income 4.83B
Sales 47.35B
FCF (ttm) 16.67B
Book/sh 34.89
Cash/sh 4.60
Employees 74,846
Insider 10d —
IPO Jul 01, 2002
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 97.73%
P/E 18.60
Forward P/E 8.13
PEG 3.78
P/S 2.17
P/B 1.23
P/C —
EV/EBITDA 5.19
EV/Sales 1.41
Quick Ratio 0.20
Current Ratio 1.00
Debt/Eq 27.37
LT Debt/Eq —
EPS (ttm) 2.31
EPS next Y 5.29
EPS Growth -11.70%
Revenue Growth 6.00%
EPS Gr Q/Q -13.80%
Rev Gr Q/Q —
Earnings (next) 2026-07-30
Earnings (prior) 2026-04-23
ROA 4.67%
ROE 6.58%
ROIC —
Gross Margin 72.36%
Oper. Margin 20.00%
Profit Margin 15.95%
Shs Outstand 2.39B
Shs Float 1.09B
Insider Own 0.00%
Instit Own 8.90%
Short Float 0.31%
Short Ratio 2.32
Short Interest 6.51M
52W High 52.68
vs 52W High -18.45%
52W Low 42.33
vs 52W Low 1.49%
Beta 0.28
Impl. Vol. 0.78%
Rel Volume 0.83
Avg Volume 3.06M
Volume 2.53M
Target (mean) $55.90
Tgt Median $54.50
Tgt Low $51.00
Tgt High $63.00
# Analysts 9
Recom Buy
Prev Close $43.67
Price $42.96
Change -1.63%
About

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$55.90
Mean price target
2. Current target
$42.96
Latest analyst target
3. DCF / Fair value
$125.37
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$42.96
Low
$51.00
High
$63.00
Mean
$55.90

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-16 down UBS Buy → Neutral —
2026-01-06 down Barclays Overweight → Equal-Weight —
2025-12-09 down Guggenheim Buy → Neutral —
2025-12-08 down JP Morgan Overweight → Neutral —
2025-09-08 up Morgan Stanley Equal-Weight → Overweight $58
2025-09-02 up Deutsche Bank Hold → Buy —
2025-08-08 up JP Morgan Neutral → Overweight —
2025-03-21 init Goldman Sachs — → Neutral $65
2024-07-26 main Argus Research Buy → Buy $60
2024-01-23 init Morgan Stanley — → Equal-Weight $55
2023-03-27 main Argus Research — → Buy $60
2022-08-12 up Deutsche Bank Sell → Hold —
2021-09-27 up SVB Leerink Market Perform → Outperform —
2021-01-15 init Deutsche Bank — → Sell —
2020-03-11 up Goldman Sachs Neutral → Buy —
2020-02-19 main Argus Research — → Buy $56
2020-02-11 init SVB Leerink — → Market Perform —
2020-01-06 up JP Morgan Neutral → Overweight —
2019-12-06 down Barclays Equal-Weight → Underweight —
2019-09-23 up Guggenheim Neutral → Buy —
News
RSS: Latest SNY news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
46,716.00
+5.49%
44,286.00
+6.41%
41,618.00
+2.61%
40,561.00
Operating Revenue
43,626.00
+6.20%
41,081.00
+8.63%
37,817.00
+0.44%
37,651.00
Cost Of Revenue
13,049.00
-1.18%
13,205.00
+4.57%
12,628.00
+6.28%
11,882.00
Reconciled Cost Of Revenue
9,147.00
-19.54%
11,368.00
+12.44%
10,110.00
-4.42%
10,578.00
Gross Profit
33,667.00
+8.32%
31,081.00
+7.21%
28,990.00
+1.08%
28,679.00
Operating Expense
24,070.00
+8.63%
22,158.00
+9.16%
20,299.00
+14.34%
17,753.00
Research And Development
7,842.00
+6.06%
7,394.00
+13.63%
6,507.00
+0.09%
6,501.00
Selling General And Administration
10,242.00
+4.30%
9,820.00
+3.63%
9,476.00
+8.43%
8,739.00
Selling And Marketing Expense
699.00
+9.73%
637.00
+17.31%
543.00
—
General And Administrative Expense
9,543.00
+3.92%
9,183.00
+2.80%
8,933.00
—
Other Gand A
9,543.00
+3.92%
9,183.00
+2.80%
8,933.00
—
Other Operating Expenses
4,210.00
+31.77%
3,195.00
+32.85%
2,405.00
+239.21%
709.00
Total Expenses
37,119.00
+4.97%
35,363.00
+7.40%
32,927.00
+11.11%
29,635.00
Operating Income
9,597.00
+7.55%
8,923.00
+2.67%
8,691.00
-20.46%
10,926.00
Total Operating Income As Reported
6,344.00
-12.52%
7,252.00
+4.20%
6,960.00
-31.51%
10,162.00
EBITDA
12,479.00
+13.57%
10,988.00
-2.96%
11,323.00
-16.19%
13,510.00
Normalized EBITDA
15,772.00
+23.96%
12,723.00
-3.15%
13,137.00
-7.98%
14,276.00
Reconciled Depreciation
5,678.00
+58.34%
3,586.00
-19.03%
4,429.00
+42.50%
3,108.00
EBIT
6,801.00
-8.12%
7,402.00
+7.37%
6,894.00
-33.72%
10,402.00
Total Unusual Items
-3,293.00
-89.80%
-1,735.00
+4.36%
-1,814.00
-136.81%
-766.00
Total Unusual Items Excluding Goodwill
-3,293.00
-89.80%
-1,735.00
+4.36%
-1,814.00
-136.81%
-766.00
Special Income Charges
-3,253.00
-94.67%
-1,671.00
+3.47%
-1,731.00
-126.57%
-764.00
Other Special Charges
255.00
-45.74%
470.00
+139.80%
196.00
+37.06%
143.00
Impairment Of Capital Assets
2,241.00
+803.63%
248.00
-72.32%
896.00
+308.86%
-429.00
Restructuring And Mergern Acquisition
1,242.00
-16.76%
1,492.00
+32.86%
1,123.00
+6.95%
1,050.00
Net Income
7,813.00
+40.52%
5,560.00
+2.96%
5,400.00
-35.49%
8,371.00
Pretax Income
6,175.00
-7.81%
6,698.00
+7.15%
6,251.00
-37.09%
9,937.00
Net Non Operating Interest Income Expense
-129.00
+73.67%
-490.00
+21.73%
-626.00
-180.72%
-223.00
Interest Expense Non Operating
626.00
-11.08%
704.00
+9.49%
643.00
+38.28%
465.00
Net Interest Income
-129.00
+73.67%
-490.00
+21.73%
-626.00
-180.72%
-223.00
Interest Expense
626.00
-11.08%
704.00
+9.49%
643.00
+38.28%
465.00
Interest Income Non Operating
331.00
-24.43%
438.00
-18.89%
540.00
+125.94%
239.00
Interest Income
331.00
-24.43%
438.00
-18.89%
540.00
+125.94%
239.00
Other Income Expense
-3,293.00
-89.80%
-1,735.00
+4.36%
-1,814.00
-136.81%
-766.00
Other Non Operating Income Expenses
—
—
—
-370.00
Gain On Sale Of Security
-40.00
+37.50%
-64.00
+22.89%
-83.00
-4050.00%
-2.00
Gain On Sale Of Business
485.00
-10.02%
539.00
+11.36%
484.00
—
Tax Provision
1,043.00
-13.37%
1,204.00
+18.39%
1,017.00
-46.73%
1,909.00
Tax Rate For Calcs
0.00
-6.03%
0.00
+10.28%
0.00
-15.10%
0.00
Tax Effect Of Unusual Items
-556.21
-78.34%
-311.88
-5.48%
-295.68
-101.05%
-147.07
Net Income Including Noncontrolling Interests
7,851.00
+39.75%
5,618.00
+3.35%
5,436.00
-35.93%
8,484.00
Net Income From Continuing Operation Net Minority Interest
4,939.00
-10.13%
5,496.00
+8.57%
5,062.00
-36.49%
7,970.00
Net Income From Continuing And Discontinued Operation
7,813.00
+40.52%
5,560.00
+2.96%
5,400.00
-35.49%
8,371.00
Net Income Continuous Operations
4,977.00
-10.39%
5,554.00
+8.94%
5,098.00
-36.93%
8,083.00
Net Income Discontinuous Operations
2,874.00
+4390.63%
64.00
-81.07%
338.00
-15.71%
401.00
Minority Interests
-38.00
+34.48%
-58.00
-61.11%
-36.00
+68.14%
-113.00
Normalized Income
7,675.79
+10.94%
6,919.12
+5.15%
6,580.32
-23.39%
8,588.93
Net Income Common Stockholders
7,813.00
+40.52%
5,560.00
+2.96%
5,400.00
-35.49%
8,371.00
Diluted EPS
3.20
+39.43%
2.29
+6.50%
2.15
-19.74%
2.69
Basic EPS
3.20
+39.43%
2.29
+6.50%
2.15
-19.74%
2.69
Basic Average Shares
2,440.80
-2.48%
2,502.80
-0.02%
2,503.40
-0.02%
2,503.80
Diluted Average Shares
2,440.80
-2.48%
2,502.80
-0.02%
2,503.40
-0.02%
2,503.80
Diluted NI Availto Com Stockholders
7,813.00
+40.52%
5,560.00
+2.96%
5,400.00
-35.49%
8,371.00
Amortization
1,776.00
+1.54%
1,749.00
-8.48%
1,911.00
+5.93%
1,804.00
Amortization Of Intangibles Income Statement
1,776.00
+1.54%
1,749.00
-8.48%
1,911.00
+5.93%
1,804.00
Depreciation Amortization Depletion Income Statement
1,776.00
+1.54%
1,749.00
-8.48%
1,911.00
+5.93%
1,804.00
Depreciation And Amortization In Income Statement
1,776.00
+1.54%
1,749.00
-8.48%
1,911.00
+5.93%
1,804.00
Earnings From Equity Interest Net Of Tax
-155.00
-358.33%
60.00
+144.12%
-136.00
-347.27%
55.00
Gain On Sale Of PPE
485.00
-10.02%
539.00
+11.36%
484.00
—
Total Other Finance Cost
-166.00
-174.11%
224.00
-57.17%
523.00
+17533.33%
-3.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
126,805.00
-4.51%
132,798.00
+5.01%
126,464.00
-0.20%
126,722.00
Current Assets
30,952.00
-27.32%
42,588.00
+38.86%
30,670.00
-10.09%
34,110.00
Cash Cash Equivalents And Short Term Investments
8,467.00
+6.81%
7,927.00
-11.73%
8,980.00
-32.98%
13,399.00
Cash And Cash Equivalents
7,657.00
+2.90%
7,441.00
-14.57%
8,710.00
-31.61%
12,736.00
Cash Equivalents
6,780.00
+9.87%
6,171.00
-14.87%
7,249.00
-36.14%
11,351.00
Cash Financial
877.00
-30.94%
1,270.00
-13.07%
1,461.00
+5.49%
1,385.00
Other Short Term Investments
810.00
+66.67%
486.00
+80.00%
270.00
-59.28%
663.00
Receivables
11,046.00
+3.92%
10,629.00
-3.72%
11,040.00
+2.74%
10,746.00
Accounts Receivable
8,410.00
+9.55%
7,677.00
-8.96%
8,433.00
+0.11%
8,424.00
Gross Accounts Receivable
8,510.00
+9.43%
7,777.00
-8.81%
8,528.00
-0.11%
8,537.00
Allowance For Doubtful Accounts Receivable
-100.00
+0.00%
-100.00
-5.26%
-95.00
+15.93%
-113.00
Other Receivables
1,480.00
+2.35%
1,446.00
-0.14%
1,448.00
+12.25%
1,290.00
Taxes Receivable
1,156.00
-23.24%
1,506.00
+29.94%
1,159.00
+12.31%
1,032.00
Inventory
10,214.00
+8.30%
9,431.00
-2.43%
9,666.00
+7.88%
8,960.00
Raw Materials
1,444.00
-0.62%
1,453.00
-6.26%
1,550.00
+5.16%
1,474.00
Work In Process
5,921.00
+11.80%
5,296.00
-0.38%
5,316.00
+6.64%
4,985.00
Finished Goods
2,849.00
+6.23%
2,682.00
-4.21%
2,800.00
+11.96%
2,501.00
Prepaid Assets
918.00
+2.57%
895.00
+16.54%
768.00
+7.56%
714.00
Assets Held For Sale Current
208.00
-98.46%
13,489.00
+89826.67%
15.00
-82.35%
85.00
Hedging Assets Current
99.00
-54.38%
217.00
+7.96%
201.00
-2.43%
206.00
Total Non Current Assets
95,853.00
+6.26%
90,210.00
-5.83%
95,794.00
+3.44%
92,611.00
Net PPE
11,511.00
-0.78%
11,601.00
-1.80%
11,814.00
+1.11%
11,684.00
Gross PPE
25,976.00
-2.62%
26,674.00
-2.80%
27,442.00
+2.41%
26,796.00
Accumulated Depreciation
-14,465.00
+4.03%
-15,073.00
+3.55%
-15,628.00
-3.41%
-15,112.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
149.00
-25.87%
201.00
-11.84%
228.00
-3.80%
237.00
Buildings And Improvements
7,062.00
-5.13%
7,444.00
-3.09%
7,681.00
+4.82%
7,328.00
Machinery Furniture Equipment
12,680.00
-1.27%
12,843.00
-4.24%
13,412.00
+0.37%
13,363.00
Construction In Progress
3,585.00
+0.34%
3,573.00
+3.60%
3,449.00
+15.12%
2,996.00
Other Properties
2,500.00
-4.32%
2,613.00
-2.21%
2,672.00
-6.96%
2,872.00
Goodwill And Other Intangible Assets
67,561.00
+2.34%
66,013.00
-10.46%
73,723.00
+3.06%
71,532.00
Goodwill
41,300.00
-4.80%
43,384.00
-12.19%
49,404.00
-0.98%
49,892.00
Other Intangible Assets
26,261.00
+16.05%
22,629.00
-6.95%
24,319.00
+12.38%
21,640.00
Investments And Advances
6,611.00
+102.85%
3,259.00
+22.24%
2,666.00
-3.58%
2,765.00
Long Term Equity Investment
2,928.00
+1004.91%
265.00
-23.85%
348.00
-48.60%
677.00
Other Investments
90.00
+76.47%
51.00
-32.89%
76.00
—
Non Current Accounts Receivable
793.00
+41.61%
560.00
+197.87%
188.00
-22.31%
242.00
Non Current Deferred Assets
8,608.00
+8.05%
7,967.00
+23.96%
6,427.00
+19.44%
5,381.00
Non Current Deferred Taxes Assets
8,608.00
+8.05%
7,967.00
+23.96%
6,427.00
+19.44%
5,381.00
Non Current Prepaid Assets
175.00
+15.13%
152.00
+33.33%
114.00
-60.14%
286.00
Total Liabilities Net Minority Interest
55,095.00
+0.28%
54,941.00
+5.43%
52,111.00
+1.05%
51,570.00
Current Liabilities
28,345.00
-2.80%
29,162.00
+20.47%
24,207.00
+0.97%
23,974.00
Payables And Accrued Expenses
9,045.00
-5.42%
9,563.00
+3.22%
9,265.00
+8.73%
8,521.00
Payables
9,045.00
-5.42%
9,563.00
+3.22%
9,265.00
+8.73%
8,521.00
Accounts Payable
7,361.00
-2.52%
7,551.00
+3.04%
7,328.00
+7.56%
6,813.00
Other Payable
560.00
-36.22%
878.00
-7.09%
945.00
+32.35%
714.00
Pensionand Other Post Retirement Benefit Plans Current
1,947.00
+0.93%
1,929.00
-8.40%
2,106.00
-2.41%
2,158.00
Total Tax Payable
1,124.00
-0.88%
1,134.00
+14.31%
992.00
-0.20%
994.00
Income Tax Payable
751.00
+7.75%
697.00
+16.75%
597.00
+4.01%
574.00
Current Debt And Capital Lease Obligation
4,614.00
+3.22%
4,470.00
+92.67%
2,320.00
-47.88%
4,451.00
Current Debt
4,342.00
+3.16%
4,209.00
+105.82%
2,045.00
-51.01%
4,174.00
Other Current Borrowings
4,342.00
+3.16%
4,209.00
+105.82%
2,045.00
-51.01%
4,174.00
Current Capital Lease Obligation
272.00
+4.21%
261.00
-5.09%
275.00
-0.72%
277.00
Current Deferred Liabilities
0.00
0.00
0.00
-100.00%
269.00
Current Deferred Revenue
0.00
0.00
0.00
-100.00%
269.00
Other Current Liabilities
12,069.00
-3.81%
12,547.00
+26.25%
9,938.00
+22.65%
8,103.00
Total Non Current Liabilities Net Minority Interest
26,750.00
+3.77%
25,779.00
-7.62%
27,904.00
+1.12%
27,596.00
Long Term Debt And Capital Lease Obligation
15,715.00
+16.96%
13,436.00
-16.56%
16,102.00
-3.93%
16,761.00
Long Term Debt
14,248.00
+20.84%
11,791.00
-17.82%
14,347.00
-3.43%
14,857.00
Long Term Capital Lease Obligation
1,467.00
-10.82%
1,645.00
-6.27%
1,755.00
-7.83%
1,904.00
Long Term Provisions
4,541.00
-21.19%
5,762.00
+9.50%
5,262.00
-9.62%
5,822.00
Defined Pension Benefit
194.00
+24.36%
156.00
-42.44%
271.00
+0.74%
269.00
Tradeand Other Payables Non Current
3,641.00
+140.81%
1,512.00
-17.92%
1,842.00
-6.92%
1,979.00
Non Current Deferred Liabilities
1,666.00
-23.08%
2,166.00
+16.64%
1,857.00
+0.87%
1,841.00
Non Current Deferred Taxes Liabilities
1,666.00
-23.08%
2,166.00
+16.64%
1,857.00
+0.87%
1,841.00
Other Non Current Liabilities
1,091.00
-60.78%
2,782.00
+3.92%
2,677.00
+124.39%
1,193.00
Stockholders Equity
71,376.00
-7.91%
77,507.00
+4.68%
74,040.00
-0.99%
74,784.00
Common Stock Equity
71,376.00
-7.91%
77,507.00
+4.68%
74,040.00
-0.99%
74,784.00
Capital Stock
2,439.00
-3.44%
2,526.00
-0.16%
2,530.00
+0.32%
2,522.00
Common Stock
2,439.00
-3.44%
2,526.00
-0.16%
2,530.00
+0.32%
2,522.00
Share Issued
1,219.50
-3.45%
1,263.12
-0.13%
1,264.80
-0.33%
1,269.04
Ordinary Shares Number
1,207.64
-3.67%
1,253.59
+0.18%
1,251.35
-0.75%
1,260.84
Treasury Shares Number
11.86
+24.44%
9.53
-29.14%
13.45
+64.03%
8.20
Additional Paid In Capital
1.00
0.00
-100.00%
313.00
+150.40%
125.00
Gains Losses Not Affecting Retained Earnings
64,436.00
-8.68%
70,561.00
+4.63%
67,437.00
-1.10%
68,185.00
Treasury Stock
1,072.00
+27.62%
840.00
-29.05%
1,184.00
+67.71%
706.00
Minority Interest
334.00
-4.57%
350.00
+11.82%
313.00
-14.95%
368.00
Other Equity Adjustments
64,436.00
-8.68%
70,561.00
+4.63%
67,437.00
-1.10%
68,185.00
Total Equity Gross Minority Interest
71,710.00
-7.90%
77,857.00
+4.71%
74,353.00
-1.06%
75,152.00
Total Capitalization
85,624.00
-4.11%
89,298.00
+1.03%
88,387.00
-1.40%
89,641.00
Working Capital
2,607.00
-80.58%
13,426.00
+107.74%
6,463.00
-36.24%
10,136.00
Invested Capital
89,966.00
-3.79%
93,507.00
+3.40%
90,432.00
-3.61%
93,815.00
Total Debt
20,329.00
+13.53%
17,906.00
-2.80%
18,422.00
-13.15%
21,212.00
Net Debt
10,933.00
+27.74%
8,559.00
+11.42%
7,682.00
+22.03%
6,295.00
Capital Lease Obligations
1,739.00
-8.76%
1,906.00
-6.11%
2,030.00
-6.92%
2,181.00
Net Tangible Assets
3,815.00
-66.81%
11,494.00
+3525.87%
317.00
-90.25%
3,252.00
Tangible Book Value
3,815.00
-66.81%
11,494.00
+3525.87%
317.00
-90.25%
3,252.00
Available For Sale Securities
2,589.00
+35.13%
1,916.00
+33.61%
1,434.00
+13.36%
1,265.00
Current Provisions
670.00
+2.60%
653.00
+12.98%
578.00
+22.46%
472.00
Derivative Product Liabilities
96.00
-20.66%
121.00
-26.22%
164.00
—
Financial Assets
9.00
0.00
0.00
0.00
Financial Assets Designatedas Fair Value Through Profitor Loss Total
1,004.00
-2.24%
1,027.00
+27.10%
808.00
-1.82%
823.00
Investmentin Financial Assets
3,593.00
+22.09%
2,943.00
+31.27%
2,242.00
+7.38%
2,088.00
Investmentsin Associatesat Cost
2,757.00
+3262.20%
82.00
-49.38%
162.00
—
Investmentsin Joint Venturesat Cost
171.00
-6.56%
183.00
-1.61%
186.00
—
Non Current Note Receivables
391.00
-22.11%
502.00
-15.06%
591.00
+30.75%
452.00
Other Equity Interest
5,572.00
+5.93%
5,260.00
+6.39%
4,944.00
+6.14%
4,658.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
10,750.00
+18.38%
9,081.00
-11.47%
10,258.00
-2.55%
10,526.00
Cash Flow From Continuing Operating Activities
10,561.00
+22.70%
8,607.00
-7.16%
9,271.00
-3.81%
9,638.00
Cash From Discontinued Operating Activities
189.00
-60.13%
474.00
-51.98%
987.00
+11.15%
888.00
Net Income From Continuing Operations
4,939.00
-10.13%
5,496.00
+8.57%
5,062.00
-36.49%
7,970.00
Depreciation Amortization Depletion
5,678.00
+58.34%
3,586.00
-19.03%
4,429.00
+42.50%
3,108.00
Depreciation
5,678.00
+58.34%
3,586.00
-19.03%
4,429.00
+42.50%
3,108.00
Depreciation And Amortization
5,678.00
+58.34%
3,586.00
-19.03%
4,429.00
+42.50%
3,108.00
Other Non Cash Items
437.00
+221.32%
136.00
-55.56%
306.00
+29.66%
236.00
Pension And Employee Benefit Expense
313.00
+12.59%
278.00
+6.92%
260.00
+11.11%
234.00
Provisionand Write Offof Assets
-100.00
-112.32%
812.00
+673.33%
105.00
+118.75%
48.00
Deferred Tax
-2,439.00
-204.11%
-802.00
+34.96%
-1,233.00
-133.08%
-529.00
Deferred Income Tax
-2,439.00
-204.11%
-802.00
+34.96%
-1,233.00
-133.08%
-529.00
Operating Gains Losses
251.00
+4283.33%
-6.00
-103.17%
189.00
+147.13%
-401.00
Change In Working Capital
1,795.00
+391.87%
-615.00
-248.91%
413.00
+152.02%
-794.00
Change In Receivables
-1,202.00
-4192.86%
-28.00
+94.07%
-472.00
+5.60%
-500.00
Changes In Account Receivables
-1,202.00
-4192.86%
-28.00
+94.07%
-472.00
+5.60%
-500.00
Change In Inventory
-39.00
+91.82%
-477.00
+44.92%
-866.00
+5.66%
-918.00
Change In Payables And Accrued Expense
398.00
-49.56%
789.00
+205.81%
258.00
-24.12%
340.00
Change In Payable
398.00
-49.56%
789.00
+205.81%
258.00
-24.12%
340.00
Change In Account Payable
398.00
-49.56%
789.00
+205.81%
258.00
-24.12%
340.00
Change In Other Working Capital
2,638.00
+393.44%
-899.00
-160.21%
1,493.00
+425.70%
284.00
Investing Cash Flow
-2,447.00
+44.47%
-4,407.00
+28.92%
-6,200.00
-198.80%
-2,075.00
Cash Flow From Continuing Investing Activities
-12,849.00
-198.95%
-4,298.00
+13.17%
-4,950.00
-133.82%
-2,117.00
Cash From Discontinued Investing Activities
10,402.00
+9643.12%
-109.00
+91.28%
-1,250.00
-3076.19%
42.00
Net PPE Purchase And Sale
-2,691.00
-55.19%
-1,734.00
+17.39%
-2,099.00
-175.10%
-763.00
Purchase Of PPE
-3,538.00
-10.74%
-3,195.00
-9.94%
-2,906.00
-38.18%
-2,103.00
Sale Of PPE
847.00
-42.03%
1,461.00
+81.04%
807.00
-39.78%
1,340.00
Capital Expenditure
-3,538.00
-10.74%
-3,195.00
-9.94%
-2,906.00
-38.18%
-2,103.00
Net Investment Purchase And Sale
—
—
-134.00
+72.54%
-488.00
Purchase Of Investment
—
—
-134.00
+72.54%
-488.00
Net Business Purchase And Sale
-10,078.00
-299.29%
-2,524.00
+3.92%
-2,627.00
-96.04%
-1,340.00
Purchase Of Business
-10,078.00
-299.29%
-2,524.00
+5.43%
-2,669.00
-81.07%
-1,474.00
Net Other Investing Changes
-80.00
-100.00%
-40.00
+82.14%
-224.00
-1500.00%
-14.00
Financing Cash Flow
-8,207.00
-42.41%
-5,763.00
+28.43%
-8,052.00
-38.33%
-5,821.00
Cash Flow From Continuing Financing Activities
-8,159.00
-41.87%
-5,751.00
+28.54%
-8,048.00
-38.59%
-5,807.00
Net Issuance Payments Of Debt
1,504.00
+268.23%
-894.00
+71.50%
-3,137.00
-154.42%
-1,233.00
Issuance Of Debt
5,559.00
0.00
-100.00%
48.00
-96.90%
1,549.00
Repayment Of Debt
-2,955.00
-210.07%
-953.00
+75.79%
-3,936.00
-31.29%
-2,998.00
Long Term Debt Issuance
5,559.00
0.00
-100.00%
48.00
-96.90%
1,549.00
Long Term Debt Payments
-2,955.00
-210.07%
-953.00
+75.79%
-3,936.00
-31.29%
-2,998.00
Net Long Term Debt Issuance
2,604.00
+373.24%
-953.00
+75.49%
-3,888.00
-168.32%
-1,449.00
Net Short Term Debt Issuance
-1,100.00
-1964.41%
59.00
-92.14%
751.00
+247.69%
216.00
Net Common Stock Issuance
-4,853.00
-4120.00%
-115.00
+71.11%
-398.00
-28.80%
-309.00
Common Stock Payments
-5,030.00
-1565.56%
-302.00
+49.07%
-593.00
-19.32%
-497.00
Common Stock Dividend Paid
-4,772.00
-1.45%
-4,704.00
-5.61%
-4,454.00
-6.86%
-4,168.00
Cash Dividends Paid
-4,772.00
-1.45%
-4,704.00
-5.61%
-4,454.00
-6.86%
-4,168.00
Repurchase Of Capital Stock
-5,030.00
-1565.56%
-302.00
+49.07%
-593.00
-19.32%
-497.00
Net Other Financing Charges
-38.00
+0.00%
-38.00
+35.59%
-59.00
+39.18%
-97.00
Changes In Cash
263.00
+120.94%
-1,256.00
+68.55%
-3,994.00
-251.86%
2,630.00
Effect Of Exchange Rate Changes
-47.00
-261.54%
-13.00
+59.38%
-32.00
-500.00%
8.00
Beginning Cash Position
7,441.00
-14.57%
8,710.00
-31.61%
12,736.00
+26.12%
10,098.00
End Cash Position
7,657.00
+2.90%
7,441.00
-14.57%
8,710.00
-31.61%
12,736.00
Free Cash Flow
7,212.00
+22.53%
5,886.00
-19.94%
7,352.00
-12.72%
8,423.00
Interest Paid Supplemental Data
485.00
-17.38%
587.00
+5.01%
559.00
+47.11%
380.00
Income Tax Paid Supplemental Data
2,885.00
-12.34%
3,291.00
+25.47%
2,623.00
+6.97%
2,452.00
Common Stock Issuance
177.00
-5.35%
187.00
-4.10%
195.00
+3.72%
188.00
Earnings Losses From Equity Investments
290.00
+253.66%
82.00
-72.01%
293.00
+751.11%
-45.00
Issuance Of Capital Stock
177.00
-5.35%
187.00
-4.10%
195.00
+3.72%
188.00
Other Cash Adjustment Inside Changein Cash
167.00
+200.00%
-167.00
0.00
0.00
Sale Of Business
0.00
0.00
-100.00%
42.00
-68.66%
134.00
Cash From Discontinued Financing Activities
-48.00
-300.00%
-12.00
-200.00%
-4.00
+71.43%
-14.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category